policy Archives

Politics By Matthew Perrone — Associated Press

FDA issues plan to ban menthol in cigarettes, cigars

Exclusive By Lev Facher

Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence

First Opinion By Richard J. Baron and Ezekiel J. Emanuel

Politicians should not be deciding what constitutes good medicine

Politics By Lev Facher

In State of the Union, Biden walks a fine line on Covid optimism

D.C. Diagnosis By Nicholas Florko

The new lightning rod in the fight over high drug prices

Politics By Lev Facher

Following Lander’s resignation, here’s who might be in line for White House science adviser

Politics By Rachel Cohrs

Major telehealth players unite ahead of tough lobbying battle

Politics By Rachel Cohrs

7 policies in Biden’s spending plan aimed at health equity

Politics By Nicholas Florko

Moderate Democrats are still seeking changes to the party’s drug pricing package

First Opinion By Stephen Asiimwe, Edith Nakku-Joloba and Aggrey Semeere

Isolated in Uganda: How Covid-19 evacuations highlight unfairness of global health partnerships

Politics By Lev Facher

Here’s how Biden can address high drug prices, without help from Congress

First Opinion By Natalie Ma

My company is developing new antibiotics. My resistant infection showed me we need them now

Politics By Rachel Cohrs

Biden abandons his push to lower drug prices

Exclusive By Rachel Cohrs and Nicholas Florko

Key Senate committee considers a carveout for small biotech companies in drug pricing reforms

Politics By Rachel Cohrs

Democrats want to let Medicare negotiate drug prices. Has pharma found a way to lessen the blow, already?

Politics By Rachel Cohrs and Lev Facher

In a new policy proposal, Biden presses Congress to let Medicare negotiate drug prices

Politics By Rachel Cohrs

Vulnerable Senate Democrats escalate a push for Medicare to negotiate drug prices

Health By Lev Facher

For the first time ever, Lander’s White House science office will have an entire wing dedicated to health

Politics By Rachel Cohrs

Senate Democrats eye drug pricing policies to fund $3.5 trillion budget deal

D.C. Diagnosis By Nicholas Florko

Are pharma mergers bad for biotech?

Politics By Rachel Cohrs

Washington’s antitrust push could limit Amazon, Google’s health care ambitions

Biotech By Damian Garde and Nicholas Florko

Calls grow for an investigation into FDA approval of Biogen’s Alzheimer’s drug

First Opinion By Sevahn Vorperian and Stephen Quake

The PASTEUR Act can help win the war against superbugs

Politics By Nicholas Florko

Powerful Democrat’s new drug pricing manifesto hints at a carveout for small biotechs

D.C. Diagnosis By Rachel Cohrs

Most Read

Judge bars Shkreli from running another public company, fines him $1.4 million

Inside the culture of fear in Eric Lander’s White House science office

Hospital, physician lobbies sue Biden administration over surprise billing regulation

How Nancy Pelosi almost killed drug pricing reform — a gamble that expanded Democrats’ final deal

Tax exemptions for nonprofit hospitals: It’s time taxpayers get their money’s worth

The Trump administration quietly spent billions in hospital funds on Operation Warp Speed

9 ways Covid-19 may forever upend the U.S. health care industry

‘They don’t want his story to end’: Efforts to save the sperm of the deceased come with heartache and tough questions

All Coverage

FDA issues plan to ban menthol in cigarettes, cigars

Lawmakers and a Pelosi aide turn lobbyist to push for new health agency’s independence

Politicians should not be deciding what constitutes good medicine

In State of the Union, Biden walks a fine line on Covid optimism

The new lightning rod in the fight over high drug prices

Following Lander’s resignation, here’s who might be in line for White House science adviser

Major telehealth players unite ahead of tough lobbying battle

7 policies in Biden’s spending plan aimed at health equity

Moderate Democrats are still seeking changes to the party’s drug pricing package

Isolated in Uganda: How Covid-19 evacuations highlight unfairness of global health partnerships

Here’s how Biden can address high drug prices, without help from Congress

My company is developing new antibiotics. My resistant infection showed me we need them now

Biden abandons his push to lower drug prices

Key Senate committee considers a carveout for small biotech companies in drug pricing reforms

Democrats want to let Medicare negotiate drug prices. Has pharma found a way to lessen the blow, already?

In a new policy proposal, Biden presses Congress to let Medicare negotiate drug prices

Vulnerable Senate Democrats escalate a push for Medicare to negotiate drug prices

For the first time ever, Lander’s White House science office will have an entire wing dedicated to health

Senate Democrats eye drug pricing policies to fund $3.5 trillion budget deal

Are pharma mergers bad for biotech?

Washington’s antitrust push could limit Amazon, Google’s health care ambitions

Calls grow for an investigation into FDA approval of Biogen’s Alzheimer’s drug

The PASTEUR Act can help win the war against superbugs

Powerful Democrat’s new drug pricing manifesto hints at a carveout for small biotechs

The lonely quest to create a commission to investigate Covid-19